Search

Search Results

• HER 2 in Gastric Cancer in Albania as a New Therapeutic Alternative

  Enkelejda Cuedari, Majlinda Ikonomi , Anila Pema (Kristo) , Blerina Çela , Shahin Kadare , Agron Dogjani

  2022-06-21

• Resistance to Trastuzumab in Clinical Her2 Breast Cancer: Possible Relation to Molecular Subtype and Cancer Stem Cells

  Maha Zickri1 , Bilgen Basgut , Amal Far , Ahmed Reda, , Sahar ElBassiony , Shaimaa Lasheen and Leila Rashed

  2016-08-20

• Drug Utilization Pattern of World’s First T-DM1 Biosimilar (UJVIRATM) For Her2+ Breast Cancer in First Year of Its Availability – An Indian Context

  Dr Gaurav Thukral, Dr Vipulkumar Thummar, Dr Priya Mehta, Dr. Vijay Janagama, Keyur Khambhati

  2023-02-25

• Future directions on Antibody-Drug Conjugates in HER-2 negative Breast Cancer: a Comprehensive Review of New Agents

  Pedro Marchiori Cacilhas, Yasmin Silva Guimarães, Pablo Moura Barrios, Pedro Emmanuel Rubini Liedke

  2024-03-20

• Correlation of PD-L1 and CD133 Expression with Metastasis in Invasive Breast Carcinoma of Luminal B Subtype

  Sofian Anwar, Bethy Surjawathy Hernowo , Birgitta Maria Dewayani , Sri Suryanti

  2019-05-10